The Cancer Letter
Inside information on cancer research and drug development
Principal investigator, NCORP grant; lung cancer specialist, Helen F. Graham Cancer Center and Research Institute, Christiana Care;
Associate professor, Thomas Jefferson University Medical School
Prior to the COVID-19 pandemic, NCI estimated that about 3% to 5% of adult cancer patients participated in clinical trials.
This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.
Only fill in if you are not human
Looking for IP Login?